A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has identified a potential biomarker of Parkinson's disease progression.

Net cash used in operating and investing activities was $45.2 million and $102.5 million for the third quarter and first nine months of 2024, respectively; quarter-end cash and restricted cash positio ...

Nearly one million people in the U.S. are living with Parkinson's Disease. Playhouse Square is rolling out a new program to ...

A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has ...

Analysis suggests that the research and development of DMTs and non-motor therapies will diversify Parkinson's treatment ...

Nir Giladi from TAU’s Faculty of Medical and Health Sciences and the Tel Aviv Sourasky Medical Center, as well as other researchers from TAU and the University of Haifa. The study was backed by the ...

The researchers note that, "despite the similarities, patients with these diseases have a different prognosis and do not ...

The study was backed by the Aufzien Family Center for the Prevention and Treatment of Parkinson's Disease at TAU. The paper ...

According to recent research, astrocyte cell transplantation could revolutionize treatments for neurological disorders such ...

The University of Pittsburgh was awarded $8 million to continue researching a new therapy for Parkinson's patients.

Experts made the discovery after analysing hours of YouTube footage of celebrities with the disease - and it paves the way ...

Parkinson’s Alert Dogs, a local non-profit, has recently released astonishing research. In 2016, PADs became the only program ...